QVIDTVM Management LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), QVIDTVM Management LLC reported 7 stock positions worth $125.0 million. Its top holding was Bio-Rad Laboratories-A (BIO) at 27.5% of the portfolio, followed by Rentokil Initial PLC-SP ADR (RTO, 21.1%) and Solventum (SOLV, 18.5%). Compared with Q1 2024, it sold out of 3, added to 2 and reduced 3. The biggest buy was Solventum (SOLV, shares +389%) and the biggest sale Wabtec (WAB, shares −26%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $125.0M (Q2 2024)
- SEC Filing
- 0001912226-24-000003 ↗ filed Aug 13, 2024
Holdings Value
Holdings 7 stocks · $125.0M
| BIO Bio-Rad Laboratories-A | 27.51% | 125,938 | $34.4M | No change |
| RTO Rentokil Initial PLC-SP ADR | 21.08% | 888,758 | $26.4M | Reduce -0.0% |
| SOLV Solventum Corp. | 18.53% | 438,217 | $23.2M | Add +389.0% |
| WAB Wabtec Corp. | 14.41% | 113,975 | $18.0M | Reduce -25.9% |
| BRC INC-A | 12.71% | 2,592,276 | $15.9M | Reduce -0.1% |
| XRAY Dentsply Sirona Inc. | 5.20% | 261,063 | $6.5M | Add +23.7% |
| OMIC Singular Genomics Systems Inc. | 0.56% | 83,558 | $706K | No change |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |